149 related articles for article (PubMed ID: 11302928)
1. In vitro metabolism of the COX-2 inhibitor DFU, including a novel glutathione adduct rearomatization.
Yergey JA; Trimble LA; Silva J; Chauret N; Li C; Therien M; Grimm E; Nicoll-Griffith DA
Drug Metab Dispos; 2001 May; 29(5):638-44. PubMed ID: 11302928
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the in vitro metabolism profile of a phosphodiesterase-IV inhibitor, CDP-840: leading to structural optimization.
Li C; Chauret N; Trimble LA; Nicoll-Griffith DA; Silva JM; MacDonald D; Perrier H; Yergey JA; Parton T; Alexander RP; Warrellow GJ
Drug Metab Dispos; 2001 Mar; 29(3):232-41. PubMed ID: 11181489
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cyclooxygenases reduces complement-induced glomerular epithelial cell injury and proteinuria in passive Heymann nephritis.
Takano T; Cybulsky AV; Cupples WA; Ajikobi DO; Papillon J; Aoudjit L
J Pharmacol Exp Ther; 2003 Apr; 305(1):240-9. PubMed ID: 12649375
[TBL] [Abstract][Full Text] [Related]
4. Use of a benzyloxy-substituted lactone cyclooxygenase-2 inhibitor as a selective fluorescent probe for CYP3A activity in primary cultured rat and human hepatocytes.
Nicoll-Griffith DA; Chauret N; Houle R; Day SH; D'Antoni M; Silva JM
Drug Metab Dispos; 2004 Dec; 32(12):1509-15. PubMed ID: 15550722
[TBL] [Abstract][Full Text] [Related]
5. Studies on the metabolism of the novel, selective cyclooxygenase-2 inhibitor indomethacin phenethylamide in rat, mouse, and human liver microsomes: identification of active metabolites.
Remmel RP; Crews BC; Kozak KR; Kalgutkar AS; Marnett LJ
Drug Metab Dispos; 2004 Jan; 32(1):113-22. PubMed ID: 14709628
[TBL] [Abstract][Full Text] [Related]
6. Oxidative bioactivation of the lactol prodrug of a lactone cyclooxygenase-2 inhibitor.
Nicoll-Griffith DA; Falgueyret JP; Silva JM; Morin PE; Trimble L; Chan CC; Clas S; Leger S; Wang Z; Yergey JA; Riendeau D
Drug Metab Dispos; 1999 Mar; 27(3):403-9. PubMed ID: 10064573
[TBL] [Abstract][Full Text] [Related]
7. Comparison of developmental toxicity of selective and non-selective cyclooxygenase-2 inhibitors in CRL:(WI)WUBR Wistar rats--DFU and piroxicam study.
Burdan F
Toxicology; 2005 Jul; 211(1-2):12-25. PubMed ID: 15863244
[TBL] [Abstract][Full Text] [Related]
8. Metabolic products and pathways of fluorotelomer alcohols in isolated rat hepatocytes.
Martin JW; Mabury SA; O'Brien PJ
Chem Biol Interact; 2005 Aug; 155(3):165-80. PubMed ID: 16098497
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of prazosin in rat, dog, and human liver microsomes and cryopreserved rat and human hepatocytes and characterization of metabolites by liquid chromatography/tandem mass spectrometry.
Erve JC; Vashishtha SC; DeMaio W; Talaat RE
Drug Metab Dispos; 2007 Jun; 35(6):908-16. PubMed ID: 17353349
[TBL] [Abstract][Full Text] [Related]
10. Mechanical analysis of tumor growth regression by the cyclooxygenase-2 inhibitor, DFU, in a Walker256 rat tumor model: importance of monocyte chemoattractant protein-1 modulation.
Muta M; Matsumoto G; Nakashima E; Toi M
Clin Cancer Res; 2006 Jan; 12(1):264-72. PubMed ID: 16397051
[TBL] [Abstract][Full Text] [Related]
11. In vitro metabolism of 2-[6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl] acetic acid (licofelone, ML3000), an inhibitor of cyclooxygenase-1 and -2 and 5-lipoxygenase.
Albrecht W; Unger A; Nussler AK; Laufer S
Drug Metab Dispos; 2008 May; 36(5):894-903. PubMed ID: 18268076
[TBL] [Abstract][Full Text] [Related]
12. Cholera toxin induces prostaglandin synthesis via post-transcriptional activation of cyclooxygenase-2 in the rat jejunum.
Beubler E; Schuligoi R; Chopra AK; Ribardo DA; Peskar BA
J Pharmacol Exp Ther; 2001 Jun; 297(3):940-5. PubMed ID: 11356914
[TBL] [Abstract][Full Text] [Related]
13. In vitro metabolism of rivaroxaban, an oral, direct factor Xa inhibitor, in liver microsomes and hepatocytes of rats, dogs, and humans.
Lang D; Freudenberger C; Weinz C
Drug Metab Dispos; 2009 May; 37(5):1046-55. PubMed ID: 19196846
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of nimesulide and 5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl) phenyl-2(5H)-furanone (DFU) on contractions of isolated pregnant human myometrium.
Karadas B; Kaya T; Guvenal T; Cetin M; Divrik I; Cetin A
Eur J Obstet Gynecol Reprod Biol; 2004 Apr; 113(2):172-7. PubMed ID: 15063955
[TBL] [Abstract][Full Text] [Related]
15. New cyclooxygenase-2 inhibitor DFU regulates vascular endothelial growth factor expression in rheumatoid synoviocytes.
Youn J; Cho ML; Kim YJ; Yun HS; Park SH; Jin CZ; Paik DJ; Kim HY
Immunol Lett; 2005 Jan; 96(2):219-24. PubMed ID: 15585326
[TBL] [Abstract][Full Text] [Related]
16. Liquid chromatography-mass spectrometry and liquid chromatography-NMR characterization of in vitro metabolites of a potent and irreversible peptidomimetic inhibitor of rhinovirus 3C protease.
Zhang KE; Hee B; Lee CA; Liang B; Potts BC
Drug Metab Dispos; 2001 May; 29(5):729-34. PubMed ID: 11302940
[TBL] [Abstract][Full Text] [Related]
17. CYP2C8- and CYP3A-mediated C-demethylation of (3-{[(4-tert-butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid (CP-533,536), an EP2 receptor-selective prostaglandin E2 agonist: characterization of metabolites by high-resolution liquid chromatography-tandem mass spectrometry and liquid chromatography/mass spectrometry-nuclear magnetic resonance.
Prakash C; Wang W; O'Connell T; Johnson KA
Drug Metab Dispos; 2008 Oct; 36(10):2093-103. PubMed ID: 18653741
[TBL] [Abstract][Full Text] [Related]
18. Liquid chromatography/nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance modulator LY335979 in rat bile and human liver microsomal incubations.
Ehlhardt WJ; Woodland JM; Baughman TM; Vandenbranden M; Wrighton SA; Kroin JS; Norman BH; Maple SR
Drug Metab Dispos; 1998 Jan; 26(1):42-51. PubMed ID: 9443851
[TBL] [Abstract][Full Text] [Related]
19. Metabolism, pharmacokinetics, and excretion of a cholesteryl ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice: characterization of unusual and novel metabolites by high-resolution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance.
Prakash C; Chen W; Rossulek M; Johnson K; Zhang C; O'Connell T; Potchoiba M; Dalvie D
Drug Metab Dispos; 2008 Oct; 36(10):2064-79. PubMed ID: 18653742
[TBL] [Abstract][Full Text] [Related]
20. Metabolism and bioactivation of 3-methylindole by human liver microsomes.
Yan Z; Easterwood LM; Maher N; Torres R; Huebert N; Yost GS
Chem Res Toxicol; 2007 Jan; 20(1):140-8. PubMed ID: 17226936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
